The city of West Valley City, Utah, currently has 2 active clinical trials seeking participants for Lymphoma research studies.
A Study of LP-284 in Relapsed or Refractory Lymphomas and Solid Tumors
Recruiting
The goal of this clinical trial is to evaluate the safety and tolerability of escalating doses of LP-284 and to determine the maximum tolerated dose (MTD) and the recommended Phase 2 dose (RP2D) in patients with relapsed or refractory (R/R) lymphomas and solid tumors. The secondary objectives are to characterize the pharmacokinetics (PK) of LP-284 and to assess clinical activity of LP-284.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/15/2024
Locations: START Mountain Region, West Valley City, Utah
Conditions: Relapsed or Refractory Lymphomas, Advanced Solid Tumor
PRO1160 for Advanced Solid and Liquid Tumors (PRO1160-001)
Recruiting
Brief Summary: This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1160 in participants with solid tumors. Participants will have solid tumor or liquid cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable). This Phase 1/2 study will have two parts. Part A of the study will find out how much and how frequently PRO1160 should be given to participants. Part B will use the dose and schedule... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/29/2024
Locations: START Mountain Cancer Center, West Valley City, Utah
Conditions: Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma